Intensive Chemo-immunotherapy as First Line Treatment in Adult Patients With Peripheral T- Cell Lymphoma

Clinical trial NCT01679860 · COMPLETED

Trial details

NCT number: NCT01679860
Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Lymphoma, T-Cell, Peripheral

Start date: 2006-11-01
Primary completion: 2011-12-01
Enrollment: 92

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.